Abstract
Neo-adjuvant versus adjuvant chemotherapy in early breast cancer: EBCTCG patient-level meta-analysis of long-term outcomes among 4756 women in 10 randomised trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have